Back to News
Market Impact: 0.4
Abbott's Q3 Earnings Call Focuses on Nutrition Spin-Off and Outlook
Source: zacks.com
M&A & RestructuringCorporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
Abbott plans to spin off its $8.5 billion Nutrition business by 2027, while cutting its 2026 sales growth outlook. The reduced outlook reflects challenges in diabetes pricing and electrophysiology.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
ABT-0.45
More News
- AI debt and French bonds face a stress test — why it may not be over
- SK Hynix shares slide after chipmaker scraps Solidigm IPO plans
- Why is SK Hynix stock sliding today?
- Apple’s iPhone Duo Hits Stores in Face of Short Supply and High Demand
- OpenAI nears up to $30 billion funding round at $1.25 trillion valuation led by UAE investors
- Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%